Joytech Healthcare Blɔg dɛn .

Effective blood pressure control Fɔ ridyus di risk fɔ arteriosclerosiss layf stayl de evolv, haypatɛyshɔn dɔn de kam mɔ ɛn mɔ. Insay Chaina, pas 30% pan di pipul dɛn we ol 35 ia ɔ pas dat gɛt ay blɔd prɛshɔn. Midul-ej ɛn ol pipul dɛn, pipul dɛn we gɛt bɔku bɔku bɔdi, ɛn di wan dɛn we gɛt famili .

Frɔm 2005, Sejoy Group dɔn bi wan dediket ɛgzibitɔ na di Kanton Faya, we dɔn briŋ wi laytst advansmɛnt dɛn na os mɛdikal divays to di wan dɛn we de bay di wɔl. Wi gladi fɔ invayt yu wan tɛm bak fɔ kam fɛn wi na Booth 9.2L11-12, usay wi go sho wi nyu JoyTech Healthcare Products.Featured Product

RSV ɛn Nebulization Therapy: Fɔ protɛkt famili healthas sizin chenj dɛn kin briŋ chenj chenj na di tɛmpracha ɛn humidity, di respiratory syncytial virus (RSV) kin kɔmɔt as wan impɔtant wɛlbɔdi kɔnsyans, mɔ fɔ di bebi dɛn, di ol pipul dɛn, ɛn di wan dɛn we gɛt wikɛd imyun sistɛm. we RSV kin PR bɔku tɛm PR .

Fɔ protɛkt di at ritm: Smat prɛvɛnshɔn ɛn monitarin fɔ AFIB ManejmɛntAtri Fibrilɛshɔn (AFIB) na wan pan di kɔmɔn kadyak aritmi dɛn, we kin rili inkrisayz di risk fɔ strok, at pwɛl, ɛn ɔl di kɔmplikeshɔn dɛn we kin apin to di at ɛn di at. Wit di global rise in aging populations en CH .

Di Hɔng Kɔŋ Ilɛktroniks Faya (Spring Ɛdyushɔn) 2025 go apin frɔm Epril 13-16 na di Hɔng Kɔŋ Kɔnvɛnshɔn ɛn Ɛgzibishin Sɛnta. As wan big manifakta fɔ mɛdikal-grɛd ilɛktronik wɛlbɔdi divays dɛn, Joytech Healthcare gladi fɔ kɔnɛkt wit di glob patna dɛn ɛn fɛn nyu biznɛs opport

Prɛsishɔn mɛnejɛmɛnt fɔ eosinophilic asthma: wan sayɛns we fɔ impɔtant kwaliti fɔ layfeosinophilic asthma (EA) na wan difrɛn sabtayp fɔ asma we dɛn kɔl abnɔmal inkris na di eosinophils na di aywe, we de mek di inflamɛns we nɔ de dɔn. Risach dɔn sho se na lɛk 40% pan AD .

Di China International Medical Equipment Fair (CMEF) 2025 go tek ples frɔm Epril 8-11 na Shanghai, we go briŋ togɛda di lida dɛn na di wɔl na di mɛdikal tɛknɔlɔji industri. As pɔsin we dɛn kin trɔst fɔ mek ay kwaliti mɛdikal divays dɛn, Joytech Healthcare kin gladi fɔ sho wi laytst nyu tin dɛn .

Nyu bɔn janda monitarin: Di wok we di kɔrɛkt tɛmpracha traknyubɔn janda na kɔmɔn kɔndishɔn, we de afɛkt lɛk 60% pan di ful-tɛm bebi dɛn ɛn 80% pan di pikin dɛn we dɛn bɔn bifo tɛm. Pan ɔl we mild jaundice kin ɔltɛm sɔlv fɔ insɛf, lɛk 15% pan di kes dɛn kin nid fɔ gɛt mɛrɛsin. Fɔ wach di tin dɛn we dɛn dɔn du kwik kwik wan na .

Lɔw blɔd prɛshɔn, ɔr hypotɛnshɔn, nɔr kin bi layf-threatening bɔt kin mek yu gɛt sɔm kayn sik lɛk diziz ɛn at palpitashɔn, wae kin afɛkt di de aktiviti ɛn prodaktiviti. Fɔ ɔndastand di ɔndalayn kɔz dɛm ɛn fɔ impruv smɔl chenj dɛm to di it ɛn layf stayl kin ɛp bɔku bɔku wan insay

Aw fɔ mek norovirus nɔ wok fayn fayn wan? Wan gayd we yu fɔ rid fɔ wɛlbɔdi biznɛs, nɔs os, ɛn di it industriNɔrovayrɔs na vayrɔs we de kɔntaji pasmak, bɔku tɛm dɛn kin kɔl am di 'Fɛri fɔ di vayrɔs dɛn' bikɔs i de skata kwik kwik wan. Akɔdin to di Wɔl Ɛlth Ɔganayzeshɔn (WHO), lɛk 685 mi